Affirm Holdings, Inc. (AFRM), the San Francisco-based "buy now, pay later" (BNPL) payments network, surged about +10.75% in Friday's trading session, with shares changing hands near $85.82 after closing at $77.49 the prior day. The move followed the company's fiscal fourth-quarter results, reported after Thursday's close, which delivered its most profitable quarter ever and forward guidance that exceeded analyst expectations across key metrics.
The earnings-driven move was powered by results that broadly beat the Street. Affirm reported revenue of approximately $1.17 billion, ahead of the roughly $1.11 billion consensus, and diluted earnings per share of $4.62, far above the $0.85 analysts had modeled. The outsized EPS figure was partly amplified by a one-time income tax benefit, but management emphasized that the quarter was still the company's most profitable on record even excluding those items.
Investors were equally focused on the outlook. For the current quarter, Affirm guided revenue to between $1.19 billion and $1.22 billion, above the $1.16 billion consensus, while projecting GMV of roughly $13.7 billion to $14.0 billion. For fiscal 2027, the company pointed to GMV exceeding $64 billion, implying growth of at least 27% on top of an already large base. That guidance reassured the market that the company's growth algorithm remains intact even at greater scale.
Underpinning the rally were signs of accelerating platform adoption. Fourth-quarter GMV rose 36% to about $14.1 billion, and active consumers grew 21% year over year to 27.8 million, with transactions per active consumer rising to 7.0. Active merchants reached roughly 571,000, up 51% from a year earlier.
The Affirm Card emerged as a key secondary driver, with its GMV surging 124% to about $2.8 billion during the quarter and active cardholders more than doubling. Direct-to-consumer GMV also climbed 49%, signaling that the card business is becoming a second growth engine alongside the core BNPL network.
The market reaction was reinforced by a flurry of analyst updates. Bank of America raised its price target to $104 from $93, citing "layering optionality on top of a conservative core algorithm," while UBS lifted its target to $90 from $82. Needham and BMO also raised their targets to $100 and $101, respectively, and Citizens reiterated a Market Outperform rating. The consensus view on the Street remains broadly constructive, with a majority of covering analysts rating the stock a buy or strong buy.
The move came with heavy volume relative to recent sessions, reflecting genuine investor conviction rather than a thin, low-liquidity drift higher. The gain stood out within the financial technology and payments sector, where the broader tape was mixed—contrasting with declines elsewhere in the payments space on the same morning. The rally pushed AFRM toward its early-July highs, breaking through short-term resistance and reclaiming levels not sustained for several weeks.
Looking ahead, investors will monitor whether Affirm can sustain its momentum as it laps difficult comparisons, including the timing shift of Prime Day and the final months of lapping lost Walmart volumes. Key watchpoints include continued Affirm Card adoption, the expansion of its global partnership with Shopify into new markets such as Australia, and the pilot of the upcoming Affirm Edge product expected in the second half of fiscal 2027. Risks remain, including a still-elevated valuation, potential consumer credit deterioration, and intense competition in the payments space. As with any post-earnings surge, the durability of the move will depend on execution against the company's own guidance in the quarters ahead.
For traders seeking a systematic edge, Tickeron's Trending AI Robots page offers a curated view of the platform's strongest-performing AI trading bots. Tickeron provides hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the most robust performance under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade. Explore the Trending AI Robots today to see which strategies are currently leading the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 10-day moving average for AFRM crossed bearishly below the 50-day moving average on August 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AFRM as a result. In 71 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for AFRM turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 32 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
AFRM moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 66 cases where AFRM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +7.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFRM advanced for three days, in 247 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
AFRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. AFRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AFRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.382) is normal, around the industry mean (4.051). P/E Ratio (12.877) is within average values for comparable stocks, (14.857). Projected Growth (PEG Ratio) (8.640) is also within normal values, averaging (3.969). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (5.862) is also within normal values, averaging (5.901).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry SavingsBanks